367 related articles for article (PubMed ID: 12025814)
1. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.
Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT
Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814
[TBL] [Abstract][Full Text] [Related]
2. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
3. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
Clark HB; Orr HT
J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
[TBL] [Abstract][Full Text] [Related]
4. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.
Hong S; Kim SJ; Ka S; Choi I; Kang S
Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161
[TBL] [Abstract][Full Text] [Related]
5. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
[TBL] [Abstract][Full Text] [Related]
6. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT
J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152
[TBL] [Abstract][Full Text] [Related]
7. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice.
Kang S; Hong S
Arch Ital Biol; 2010 Dec; 148(4):351-63. PubMed ID: 21308649
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.
D'Souza DR; Wei J; Shao Q; Hebert MD; Subramony SH; Vig PJ
Neurosci Lett; 2006 Nov; 409(1):5-9. PubMed ID: 17045396
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB
J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018
[TBL] [Abstract][Full Text] [Related]
10. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG
J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637
[TBL] [Abstract][Full Text] [Related]
11. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776.
Duvick L; Barnes J; Ebner B; Agrawal S; Andresen M; Lim J; Giesler GJ; Zoghbi HY; Orr HT
Neuron; 2010 Sep; 67(6):929-35. PubMed ID: 20869591
[TBL] [Abstract][Full Text] [Related]
12. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
Klement IA; Skinner PJ; Kaytor MD; Yi H; Hersch SM; Clark HB; Zoghbi HY; Orr HT
Cell; 1998 Oct; 95(1):41-53. PubMed ID: 9778246
[TBL] [Abstract][Full Text] [Related]
13. p80 coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product.
Hong S; Ka S; Kim S; Park Y; Kang S
Biochim Biophys Acta; 2003 May; 1638(1):35-42. PubMed ID: 12757932
[TBL] [Abstract][Full Text] [Related]
14. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
[TBL] [Abstract][Full Text] [Related]
15. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
Yue S; Serra HG; Zoghbi HY; Orr HT
Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
[TBL] [Abstract][Full Text] [Related]
16. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
[TBL] [Abstract][Full Text] [Related]
17. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.
Watase K; Weeber EJ; Xu B; Antalffy B; Yuva-Paylor L; Hashimoto K; Kano M; Atkinson R; Sun Y; Armstrong DL; Sweatt JD; Orr HT; Paylor R; Zoghbi HY
Neuron; 2002 Jun; 34(6):905-19. PubMed ID: 12086639
[TBL] [Abstract][Full Text] [Related]
18. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice.
Serra HG; Byam CE; Lande JD; Tousey SK; Zoghbi HY; Orr HT
Hum Mol Genet; 2004 Oct; 13(20):2535-43. PubMed ID: 15317756
[TBL] [Abstract][Full Text] [Related]
19. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.
Orr HT
Prog Neurobiol; 2012 Dec; 99(3):179-85. PubMed ID: 22531670
[TBL] [Abstract][Full Text] [Related]
20. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures.
Skinner PJ; Koshy BT; Cummings CJ; Klement IA; Helin K; Servadio A; Zoghbi HY; Orr HT
Nature; 1997 Oct; 389(6654):971-4. PubMed ID: 9353120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
